NGENUITY for Glaucoma
Byers Eye Institute, Palo Alto, CA
NGENUITY +1 moreN/AWaitlist AvailableLed by Robert T Chang, MDResearch Sponsored by Stanford UniversityEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with mild to moderate primary open angle glaucoma as defined by AGS with visually significant age-related cataract undergoing uncomplicated cataract surgery and Hydrus microstent
Be older than 18 years old
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upup to 5 minutes
Awards & highlights
No Placebo-Only Group
Study Summary
This trial is testing whether a new 3D camera system is better than the conventional microscope for placement of a Hydrus microstent by new users.
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowSelect...
You have mild to moderate glaucoma and cataracts, and you are scheduled for a simple cataract surgery with the Hydrus microstent.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Time of first cannula in until satisfactory stent placement and cannula out
Secondary outcome measures
Change in attending/fellow questionnaire
Number of anterior chamber entry and reentry attempts during stent placement
Number of microscope focus or position readjustments needed during stent placement
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: NGENUITYExperimental Treatment1 Intervention
Research fellow participants utilize NGENUITY during micro-stent placement
Group II: Conventional microscopeActive Control1 Intervention
Research fellow participants utilize conventional microscope during micro-stent placement
Find a site
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,258 Previous Clinical Trials
17,273,673 Total Patients Enrolled
11 Trials studying Glaucoma
545 Patients Enrolled for Glaucoma
Alcon VisionUNKNOWN
Robert T Chang, MDPrincipal Investigator
Stanford UniversityMedia Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are new participants currently being enrolled in this research experiment?
"According to the records available on clinicaltrials.gov, this particular research project is not accepting participants at this time - though it was initially posted in October 2022 and updated last September. Fortunately, there are 206 other studies actively seeking candidates for involvement right now."
Answered by AI